Eukarÿs has developed C3P3 RNA polymerase: a patented bioengineered enzyme which demultiplies biomedicines upstream production yields in mammalian cells - cost reduction - ability to produce hard-to-express medicines - universal: any antibody, recombinant protein, VLP... - no investment in new equipments - compatible with all existing technologies - no impact on biologic quality: glycosylation, folding... Full freedom to operate World-class Awards: Prix Galien, Sanofi Golden Ticket 9 publications: Nucleic Acids Research, Nature scientific reports, Journal of Virology... 3 patent families
Eukarÿs has developed C3P3 RNA polymerase: a patented bioengineered enzyme which demultiplies biomedicines upstream production yields in mammalian cells - cost reduction - ability to produce hard-to-express medicines - universal: any antibody, recombinant protein, VLP... - no investment in new equipments - compatible with all existing technologies - no impact on biologic quality: glycosylation, folding... Full freedom to operate World-class Awards: Prix Galien, Sanofi Golden Ticket 9 publications: Nucleic Acids Research, Nature scientific reports, Journal of Virology... 3 patent families
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- 2010
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- 4, Rue Pierre Fontaine Ile-de-France Évry
- City
- Moneragala
- Region
- Moneragala
- Postal Code
- 91000
- Country
- Sri Lanka